Pulmonary arterial hypertension (PAH) is a rare but life-threatening disease that progressively damages the blood vessels of the lungs and can lead to heart failure. A new review published in the Chinese Medical Journal highlights how advances in genetics, immune biology, and metabolism are transforming scientists' understanding of PAH. By bringing together recent discoveries and emerging therapies, the study suggests that targeting the disease's underlying drivers could pave the way for more effective treatments.

Artificial intelligence (AI) is emerging as a promising domain for inflammatory bowel disease (IBD) care across multiple clinical settings. In a review study, researchers highlight how AI may support disease monitoring, dysplasia detection, outcome prediction, treatment selection, and precision medicine, while emphasizing that clinical translation still requires multicenter validation, transparent models, ethical safeguards, and integration with clinician oversight before routine practice is widely adopted.